VALNEVA SE SPON ADS EACH REPR 2 ORD SHS
(NASDAQ: VALN)

Valneva SE is a specialty vaccine company, which focuses on the development, manufacturing, and commercialization of prophylactic vaccines for infectious diseases. It operates through the following segments: Commercialized Products, COVID, Vaccine Candidates, and Technologies and Services. The Commercialized Products segment markets vaccines, currently IXIARO and DUKORAL vaccines, as well as third-party products. The COVID segment develops, manufactures, and distribute related to COVID-19 vaccine candidate, VLA2001. The Vaccine Candidates segment focuses on proprietary research and development programs aiming to generate new approvable products to generate future cash flows from product sales or from commercialization through partnering with pharmaceutical companies. The Technologies and Services segment offers services and inventions at a commercialization stage. The company was founded on April 7, 1999 and is headquartered in Saint-Herblain, France.

7.980

+0.025 (+0.31%)
Range - - -   (-%)
Open -
Previous Close 7.955
Bid Price 12.350
Bid Volume 9
Ask Price 12.510
Ask Volume 10
Volume 4,629
Value -
Remark
Delayed prices. Updated at 28 Mar 2024 23:54.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis